SCHEMBL1103389

SCHEMBL1103389

c1ccc(-c2c3ccccc3c(-c3ccccc3-c3ccc4ccccc4c3)c3cnc4ccccc4c23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.46
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
RECQL P46063 1/20 0.40
RAB9A P51151 1/20 0.40
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
MTOR P42345 1/20 0.38
PIK3CG P48736 1/20 0.38
DHFR P00374 1/20 0.38
KDM4E B2RXH2 4/20 0.37
HDAC4 P56524 1/20 0.37
HDAC2 Q92769 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103506 0.95 MET (0.43) METADORA2AADORA1ESR1ESR2
SCHEMBL1103508 0.95 MET (0.47) METADORA2AADORA1ESR2SMN1; SMN2
SCHEMBL1103509 0.94 MET (0.42) METADORA2AADORA1ESR1ESR2
SCHEMBL1103359 0.94 MET (0.48) METADORA2AADORA1ESR2SMN1; SMN2
SCHEMBL1103386 0.93 MET (0.43) METADORA2AADORA1ESR1ESR2
SCHEMBL1103459 0.91 ESR1 (0.41) METADORA2AADORA1ESR1ESR2
SCHEMBL1103448 0.90 ESR1 (0.48) METADORA2AADORA1ESR1ESR2
SCHEMBL1103493 0.90 ESR1 (0.48) METADORA2AADORA1ESR1ESR2
SCHEMBL1103381 0.90 ESR1 (0.48) METADORA2AADORA1ESR1ESR2
SCHEMBL1103484 0.90 ESR1 (0.48) METADORA2AADORA1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 MET 4191/4885ADORA2A 3222/4885ADORA1 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.